Error: Could not add to watchlist. X
+ Watchlist

Soligenix Inc

SNGX:US
NASDAQ CM
2.100
USD
0.050
2.33%
As of 4:30 PM EDT 6/22/2017
Open
2.110
Day Range
2.100 - 2.180
Volume
30,851
Previous Close
2.150
52Wk Range
1.900 - 8.500
1 Yr Return
-71.13%
Before it's here, it's on the Bloomberg Terminal.
Learn More
Open
2.110
Day Range
2.100 - 2.180
Volume
30,851
Previous Close
2.150
52Wk Range
1.900 - 8.500
1 Yr Return
-71.13%
YTD Return
-6.67%
Current P/E Ratio (TTM)
-
Earnings per Share (USD) (TTM)
-1.105
Market Cap (m USD)
12.196
Shares Outstanding (m)
5.673
Price/Sales (TTM)
0.81
Dividend Indicated Gross Yield
-
Sector
Health Care
% Price Change
+1.05%
% Price Change
+1.26%

Related Videos

There are currently no related videos for this ticker. Please check back later.
Profile
Soligenix, Inc. develops therapeutics and vaccines. The Company researches treatments for gastrointestinal Graft-versus-Host disease and cancer, and develops vaccines for military and civilian applications.
Address
29 Emmons Drive
Suite C-10
Princeton, NJ 08540
United States
Phone
1-609-538-8200
  • Christopher J Schaber
    Chairman/President/CEO
  • Karen R Krumeich
    Senior VP/CFO
  • Richard Straube
    Senior VP/Chief Medical Ofcr
  • Oreola Donini
    Senior VP/Chief Scientific Ofcr
Show More